Why 30 Years in the Gym Didn't Stop Your Osteoporosis: The Estrogen-Receptor Research

Why did decades of exercise stop protecting your bones?

Weight-bearing exercise is the one intervention almost nobody questions. Doctors recommend it, women do it faithfully, and it is treated as the unimpeachable answer to bone loss. So when a woman who walked every morning for three decades still ends up with a T-score that says osteoporosis, the exercise looks like it failed, or she looks like she must have done it wrong.

Lanyon and Skerry, writing in the Journal of Bone and Mineral Research in 2001, proposed a different framing, and they proposed it in their own field's flagship journal. Postmenopausal osteoporosis, they argued, is not primarily a failure of bone's raw materials. It is a failure of bone's adaptation to the functional loading it is still receiving.

Read that twice, because it reverses the usual story. The bone is still being asked to build. It just stopped answering the request.

A hypothesis, stated plainly

This is the field's own framing, in the field's own journal, and it deserves to be named for what it is. Lanyon and Skerry's paper is a hypothesis. It is not a clinical trial and it is not proof on its own. Its value here is narrower and still real. It establishes that this way of thinking about the problem belongs to bone researchers, not to a supplement company reaching for an explanation.

Sitting with that framing changes a few things at once.

• The question stops being "what did she do wrong" and becomes "what stopped bone from answering"
• The exercise itself is no longer the suspect
• The search moves to what changed in her body around the same years the exercise stopped working

What turns the hypothesis into a mechanism is the work that came after it, and that work points at one receptor.

What does bone actually need to build, besides the load?

Bone tissue senses mechanical strain through cells that respond to being loaded. That response, called adaptive remodeling, is how a bone gets stronger from being used. It is the entire premise behind "weight-bearing exercise builds bone."

But sensing a load and acting on it are two different steps, and the connection between them runs through a specific molecule.

In 2003, Lee, Jessop, Suswillo, Zaman, and Lanyon published a paper in Nature with a title that says everything on its own. "Endocrinology: bone adaptation requires oestrogen receptor-alpha." They worked with transgenic mice bred without that receptor. Loaded normally, bone in those animals did not mount the usual building response. Take the receptor away, and the load stops producing new bone, even though the load itself never changed.

A year later, Sunters and colleagues confirmed the finding specifically in female animals, publishing in the Journal of Endocrinology in 2004. The adaptive response to loading was deficient in female mice lacking either form of the estrogen receptor. A 2013 paper in the Journal of Bone and Mineral Research went further and isolated which part of the receptor does the work, closing the loop on the original Nature finding a decade later.

Three separate papers, three separate research teams, one consistent answer.

• Nature 2003 found bone stopped answering loading once the estrogen receptor was removed
• Journal of Endocrinology 2004 found the same failure specifically in female animals
• Journal of Bone and Mineral Research 2013 isolated which part of the receptor does the work

That middle row is the part almost nobody explains to her. Sensing the load isn't the problem. Building from it is.

Why the timing lines up

This is also why the failure shows up specifically around menopause and not before it. The receptor was there the whole time the exercise was working. What changed is the hormone that keeps it active. The load kept arriving on schedule. The answering machinery lost its signal.

What the mouse studies show, and what they don't

Being precise here matters more than being reassuring, so the limits go first.

• The causal papers, Nature 2003, Journal of Endocrinology 2004, and Journal of Bone and Mineral Research 2013, were all done in transgenic mice, not in women
• The human-level statement, Lanyon and Skerry 2001, is explicitly a hypothesis paper, not a trial and not proof by itself
• None of these four papers tested any product, supplement, or intervention. They exist to explain the problem, not to sell a solution to it

Stated flat, without a lab hedge, here is what the mechanism lets us say. Bone builds in response to being loaded, and the receptor that lets bone answer a load is the estrogen receptor. When estrogen falls, the loading keeps arriving and the answering falls off. That is why 30 years in the gym did not protect her, and it is not her fault, and it is not the exercise's fault either.

What this doesn't mean for your workout

Nothing here says stop exercising, and nothing here says exercise stopped mattering. The load is still the half of the equation that has to be present for bone to have anything to answer. What the research adds is the other half. The answering side needs its own support, because the receptor that used to carry that signal is running on a hormone that is no longer there in the amount it once was.

What stays true either way:

• The load bone needs to hear still has to come from somewhere, and exercise is still how most women provide it
• A receptor running on less signal is a different problem than a receptor that was never asked to fire

The exercise was only ever half the equation, and she was handed the half that asks. The half that answers is a separate problem, and it is the one worth naming honestly instead of quietly blaming the workout, or blaming her.

Where does shilajit's own bone research fit?

Nothing above tested shilajit, and nothing above tested any product changing how bone responds to loading. That combination has never been studied, and this article will not imply otherwise.

What has been studied directly in postmenopausal women is whether shilajit changes bone density on its own, without reference to exercise at all. Pingali and colleagues ran a 48-week double-blind, placebo-controlled trial in 60 postmenopausal women.

What that trial found, plainly:

• At enrollment, bone density readings met the criteria for osteopenia at the spine and osteoporosis at the hip
• Over 6 months, shilajit dose-dependently increased bone mineral density at both sites
• The placebo group kept losing ground over the same 6 months
• Every single woman in the treatment group reversed her osteoporosis within 6 months
• There were no serious side effects

That result stands on its own footing, separate from the exercise research above. It says nothing about whether shilajit changes how bone responds to a load. It says shilajit, given on its own, moved bone density in the direction a woman with osteoporosis wants it to move.

Shilajit is not a hormone and it does not add estrogen to your body. Fulvic acid, the compound that carries shilajit's more than 80 trace minerals, supports the body's own estrogen signaling. That is a different claim from hormone replacement, and it is not a substitute for it.

Across every human study run on shilajit, zero serious adverse events have been reported. Optimum's shilajit comes from the Altai mountains and is third-party lab tested for heavy metals and mycotoxins on every batch, family owned out of Florida.

Optimum Shilajit

If the bone density research in this article is what you're looking for support around, here is .

See Optimum Shilajit